Search

Search Constraints

You searched for: Author/Creator Zalcman, Gerard

Search Results

1. Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations. (May 2022)

4. Management of immune-related adverse events resulting from immune checkpoint blockade. Issue 3 (4th March 2019)

5. Phase Ib/II study of the pan-cyclin-dependent kinase inhibitor roniciclib in combination with chemotherapy in patients with extensive-disease small-cell lung cancer. (September 2018)

6. Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial. Issue 1 (January 2022)

7. Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics. (July 2021)

8. STK38 kinase acts as XPO1 gatekeeper regulating the nuclear export of autophagy proteins and other cargoes. (23rd September 2019)